xAnts

xAnts

en-US

Breakthrough Approval: FDA Gives Green Light to Zepbound for Sleep Apnea Treatment

2024-12-20The Washington Post
Breakthrough Approval: FDA Gives Green Light to Zepbound for Sleep Apnea Treatment

In a significant development, the FDA has approved Eli Lilly's innovative weight-loss drug Zepbound for the treatment of sleep apnea, a prevalent yet potentially severe sleep disorder. This breakthrough approval marks a new era in the management of s ...Read more

Recommendations